CHEMOURS ($CC) posted quarterly earnings results for Q3 2026 on Monday, November 2nd. The company reported earnings of $0.21 per share, missing estimates of $0.27 by $0.06. The company also reported revenue of $1,540,000,000, missing estimates of $1,578,383,772 by $-38,383,772.
Stock price change since market close: +1.82%
You can see Quiver Quantitative's $CC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CHEMOURS Insider Trading Activity
CHEMOURS insiders have traded $CC stock on the open market 7 times in the past 6 months. Of those trades, 7 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CC stock by insiders over the last 6 months:
- ALISTER COWAN purchased 13,000 shares for an estimated $203,060
- MARY B CRANSTON purchased 6,000 shares for an estimated $94,950
- DENISE DIGNAM (Chief Executive Officer) purchased 3,378 shares for an estimated $50,501
- SHANE HOSTETTER (Chief Financial Officer) purchased 3,350 shares for an estimated $50,049
- CALDERON GERARDO FAMILIAR (See Remarks) purchased 1,935 shares for an estimated $30,050
- JOSEPH T. MARTINKO (See Remarks) purchased 1,939 shares for an estimated $30,008
- MICHAEL ROBERT FOLEY (See Remarks) purchased 1,934 shares for an estimated $29,999
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
CHEMOURS Hedge Fund Activity
We have seen 201 institutional investors add shares of CHEMOURS stock to their portfolio, and 202 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 4,199,395 shares (+inf%) to their portfolio in Q2 2026, for an estimated $86,171,585
- VOYA INVESTMENT MANAGEMENT LLC added 3,502,649 shares (+8329.1%) to their portfolio in Q2 2026, for an estimated $71,874,357
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 2,044,387 shares (+inf%) to their portfolio in Q2 2026, for an estimated $41,950,821
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,978,087 shares (+inf%) to their portfolio in Q2 2026, for an estimated $40,590,345
- COOPER CREEK PARTNERS MANAGEMENT LLC added 1,975,245 shares (+114.4%) to their portfolio in Q2 2026, for an estimated $40,532,027
- NUVEEN, LLC added 1,270,368 shares (+349.5%) to their portfolio in Q2 2026, for an estimated $26,067,951
- HIGHLAND PEAK CAPITAL, LLC added 1,183,210 shares (+81.1%) to their portfolio in Q2 2026, for an estimated $24,279,469
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
CHEMOURS Price Targets
Multiple analysts have issued price targets for $CC recently. We have seen 5 analysts offer price targets for $CC in the last 6 months, with a median target of $25.0.
Here are some recent targets:
- John Roberts from Mizuho set a target price of $25.0 on 07/01/2026
- Jeffrey Zekauskas from JP Morgan set a target price of $22.0 on 05/21/2026
- Arun Viswanathan from RBC Capital set a target price of $29.0 on 05/11/2026
- Vincent Andrews from Morgan Stanley set a target price of $21.0 on 05/11/2026
- Joshua Spector from UBS set a target price of $30.0 on 05/08/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
